Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.610
0.00 (0.00%)
At close: Jan 21, 2026
21.32%
Market Cap58.81M
Revenue (ttm)33.42M
Net Income (ttm)6.98M
Shares Out18.00M
EPS (ttm)0.39
PE Ratio8.44
Forward PEn/a
Dividend0.06 (1.74%)
Ex-Dividend DateApr 30, 2025
Volume40
Average Volume2,211
Open4.610
Previous Closen/a
Day's Range4.610 - 4.610
52-Week Range3.550 - 4.820
Beta-0.01
RSI52.88
Earnings DateDec 29, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD Financial Statements